PC
XBI icon

Pecaut & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pecaut & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,450
Closed -$327K – 79
2024
Q1 		$327K Sell
3,450
-600
-15% -$55.7K 0.12% 64
2023
Q4 		$362K Buy
+4,050
New +$301K 0.15% 64

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Pecaut & Co's XBI Position: Q2 2024 in Review

Pecaut & Co sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 3,450 shares — an estimated $327K sold.

Pecaut & Co first reported a position in XBI in Q4 2023 and held it in 2 quarters. The position peaked at $362K in Q4 2023. 762 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • Pecaut & Co reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • Pecaut & Co sold 3,450 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $327K.
  • Pecaut & Co first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 2 quarters.
  • Pecaut & Co's State Street SPDR S&P Biotech ETF position peaked at $362K in Q4 2023.
  • 762 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Pecaut & Co's 13F filing for Q2 2024, filed 7 Aug 2024.